For instance, an [18F]fluorodeoxyglucose (FDG) PET scan could be appropriate for patients with a suspected frontotemporal dementia disorder, a dopamine transporter scan (DaTscan) for those with possible Lewy body etiology and magnetic resonance imaging (MRI) for patients with suspected vascular dementia. The gene discussed is SLC6A3; the disease is vascular dementia.